Trimetazidine – Cardiology MCQ
Trimetazidine is an antianginal agent which acts by inhibition of:
A. Beta oxidation of fatty acids
B. Anaerobic metabolism of glucose
C. Calcium channels
D. Beta adrenergic receptors
Please check the YouTube video above for discussion
Related Posts
-
Reversed mismatch on PET scan – Cardiology MCQ
2 Comments | Jul 2, 2016 -
Carotid artery stenting in asymptomatic cases – Cardiology MCQ
No Comments | Nov 1, 2013 -
Coronary artery disease in diabetics – Cardiology MCQ
No Comments | Nov 2, 2013 -
Loop diuretics – Cardiology MCQ
No Comments | Jun 2, 2015
About The Author
Johnson Francis
Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal